Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Accretion Nutraveda Ltd

BSE: 544694 · Pharmaceuticals & Biotechnology · 12 announcements

Share price
₹304.50
Market cap
₹220.5 Cr
Revenue (annual)
₹33.60 Cr
Net profit (annual)
₹5.07 Cr
P/E (TTM)
43.5×Sector 47.4×
Promoter holding
73.48%+0.00% QoQ
FII holding
1.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

21:19 IST BSE
Annual General Meeting

Accretion Nutraveda Annual General Meeting

Accretion Nutraveda Limited issued a Notice of Postal Ballot to seek shareholder approval for the alteration of its Memorandum of Association. Voting concludes on October 9, 2026.

12:39 IST BSE
Board Meeting Outcome

Accretion Nutraveda Board Meeting Outcome

Accretion Nutraveda's board approved altering its Object Clause to include nutraceuticals and hospitals. The board also proposed increasing borrowing limits and advancing loans to related entities.

18:36 IST BSE
Annual General Meeting

Accretion Nutraveda Annual General Meeting

Accretion Nutraveda Limited held its 5th Annual General Meeting on 27th August, 2026, where shareholders transacted routine business, including the adoption of financial statements.